CBER dispute resolution procedures
This article was originally published in The Gray Sheet
Executive Summary
Draft guidance document released March 19 by FDA's Center for Biologics Evaluation and Research outlines the center's process for resolving scientific and procedural disputes that cannot be handled at the division level. Comments on the draft are due May 18. FDA's Center for Devices and Radiological Health is expected to release its own guidance on the issue shortly